Robin Perle Byrd , ARNP
Nurse Practitioner • Tallahassee, FL
1705 S Adams St
Tallahassee, FL 323015406
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on April 25, 2007; this date does not establish years in practice.
-
Published CMS data list 4,400 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Ozempic (Semaglutide) — 469 prescription fills, including refills.
- Levothyroxine Sodium — 460 prescription fills, including refills.
- Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) — 374 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 57 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 90% of clinicians listed under Nurse Practitioner in Tallahassee, FL (2024, 68 clinicians with data). Median for this group: 403. Middle half: 127 to 1,221.
More Part D prescriptions than 90% of clinicians listed under Nurse Practitioner in Florida (2024, 3,506 clinicians with data). Median for this group: 306. Middle half: 76 to 1,100.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 3,985 in 2020 to 4,400 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
1705 S Adams St
Tallahassee, FL 323015406
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Nurse Practitioner: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
9,951 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,543,989 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $93.12 across 3 records.
By nature of payment
- Food and Beverage: $93.12 across 3 records.
Reporting-company totals
- Tandem Diabetes Care, Inc.: $37.21 across 1 record.
- BETA BIONICS, INC.: $28.46 across 1 record.
- Insulet Corporation: $27.45 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Tallahassee and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Nurse Practitioner in Tallahassee, FL (2024, 68 clinicians with data). Median for this group: 403. Middle half: 127 to 1,221.
More Part D prescriptions than 90% of clinicians listed under Nurse Practitioner in Florida (2024, 3,506 clinicians with data). Median for this group: 306. Middle half: 76 to 1,100.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Nurse Practitioner in Tallahassee, FL (2024, 68 clinicians with data). Median for this group: $29,758. Middle half: $2,579 to $168,842.
A higher Part D drug cost than 95% of clinicians listed under Nurse Practitioner in Florida (2024, 3,506 clinicians with data). Median for this group: $18,227. Middle half: $1,370 to $130,581.
147 active clinicians are listed under Nurse Practitioner with a practice address in Tallahassee, FL (8,853 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Tallahassee
6.8% of these 147 clinicians have the CMS telehealth indicator.
49% of these 147 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 10% from 3,985 in 2020 to 4,400 in 2024.
- 2020: 3,985
- 2021: 3,683
- 2022: 3,307
- 2023: 4,224
- 2024: 4,400
-
30-day fills
30-day fills increased 16% from 8,561 in 2020 to 9,951 in 2024.
- 2020: 8,561
- 2021: 8,121
- 2022: 7,376
- 2023: 9,642
- 2024: 9,951
-
Part D drug cost
Part D drug cost increased 11% from $1,387,436 in 2020 to $1,543,989 in 2024.
- 2020: $1,387,436
- 2021: $1,350,234
- 2022: $1,358,553
- 2023: $2,099,521
- 2024: $1,543,989
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $91.09 in 2021 to $93.12 in 2025.
- 2021: $91.09
- 2022: $45.05
- 2023: $73.45
- 2024: $199.27
- 2025: $93.12
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): fewer than 11 records totaling $93.12.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Tandem Diabetes Care, Inc. |
Food and Beverage
In-kind items and services
|
t:slim X2 Insulin Pump with Control-IQ | General | $37.21 |
| BETA BIONICS, INC. |
Food and Beverage
In-kind items and services
|
iLet Bionic Pancreas | General | $28.46 |
| Insulet Corporation |
Food and Beverage
Cash or cash equivalent
|
Omnipod | General | $27.45 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Ozempic | Semaglutide | 469 | 16,586 | $525,766.97 | 78 |
| Levothyroxine Sodium | Levothyroxine Sodium | 460 | 39,101 | $8,246.48 | 142 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 374 | 27,409 | $53,964.14 | 124 |
| Humalog Kwikpen U-100 | Insulin Lispro | 317 | 18,225 | $77,192.86 | 88 |
| Metformin Hcl | Metformin Hcl | 240 | 21,164 | $2,925.92 | 77 |
| Metformin Hcl Er | Metformin Hcl | 222 | 18,984 | $2,614.68 | 68 |
| Synthroid | Levothyroxine Sodium | 196 | 14,311 | $21,508.05 | 49 |
| Mounjaro | Tirzepatide | 145 | 4,824 | $176,085.68 | 32 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 130 | 7,914 | $11,971.56 | 53 |
| Atorvastatin Calcium | Atorvastatin Calcium | 124 | 10,860 | $2,023.88 | 39 |
| Glimepiride | Glimepiride | 122 | 10,770 | $1,801.18 | 35 |
| Trulicity | Dulaglutide | 119 | 3,706 | $115,582.90 | 16 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 87 | 7,680 | $1,548.11 | 25 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 86 | 5,435 | $7,611.64 | 33 |
| Tresiba Flextouch U-100 | Insulin Degludec | 85 | 5,090 | $55,324.04 | 34 |
| Methimazole | Methimazole | 75 | 6,548 | $1,888.55 | 23 |
| Humalog | Insulin Lispro | 64 | 3,497 | $13,515.31 | 17 |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 64 | 3,025 | $23,153.27 | 15 |
| Januvia | Sitagliptin Phosphate | 60 | 3,070 | $55,746.59 | 13 |
| Amlodipine Besylate | Amlodipine Besylate | 57 | 4,330 | $533.30 | 18 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 49 | 2,415 | $6,418.04 | 13 |
| Jardiance | Empagliflozin | 49 | 3,570 | $63,992.83 | 14 |
| Novolog Flexpen | Insulin Aspart | 48 | 2,616 | $13,871.69 | 13 |
| Tradjenta | Linagliptin | 39 | 2,610 | $42,497.21 | — |
| Glipizide | Glipizide | 38 | 3,000 | $323.55 | 13 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 363L00000X
(1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Endocrinology, Diabetes & Metabolism
Doctor of Medicine (M.D.)
Internal Medicine - Endocrinology, Diabetes & Metabolism
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated April 25, 2007.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Nurse Practitioners in Tallahassee
- Melinda Schrock, NP
- Joyce Dwyer, ARNP
- Romanise Mcswain, BSN, FNP-C
- Mylinh Seagull, NP
- Angela Myers, ARNP
- Tara Dennis, APRN
Mailing Address
6653 Man O War Trl
Tallahassee, FL 323091637
Phone: 8508940615